StonvexLoading…
StonvexStonvexStonvexCore line items from FTEK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.08M | $26.68M | $19.43M | $11.94M |
Operating Income | $-1.60M | $-3.68M | $-2.26M | $-2.26M |
Net Income | $-1.35M | $-2.32M | $-1.13M | $-689.00K |
EPS (Diluted) | $-0.04 | $-0.08 | $-0.04 | $-0.05 |
Total Assets | $44.49M | $47.18M | $47.91M | $47.00M |
Total Liabilities | $5.93M | $7.25M | $6.90M | $6.34M |
Cash & Equivalents | $9.11M | $11.94M | $13.68M | $10.59M |
Free Cash Flow OCF − CapEx | $-1.17M | $2.34M | $4.35M | $1.39M |
Shares Outstanding | 31.16M | 31.07M | 31.07M | 31.07M |